962                                   LAWS OF MARYLAND                           CH. 519

of the United States, or official National Formulary or any supple-
ment of them; (ii) articles intended for use in the diagnosis, cure,
mitigation, treatment or prevention of disease in man or animals;
(in) articles (other than food) intended to affect the structure or
any function of the body of man or animals; (iv) articles intended
for use as a component of any article specified in (i), (ii) or (iii)
of this subsection. The term "drug" however, does not include de-
vices or their components, parts or accessories.

(4)    The term "counterfeit drug" means a drug, or container
or labeling of a drug which without authorization bears the trade-
mark, trade name, or other identifying mark, imprint or device
(or any likeness thereof), of a drug manufacturer, processor, packer,
or distributor other than the person or persons who in fact manu-
factured, processed, packed or distributed such drug, and which
thereby is falsely represented or purported to be the product of,
or to have been packed or distributed by, such other drug manu-
facturer, processor, packer or distributor.

(5)    The term "depressant or stimulant drug" means (i) any
drug containing any quantity of barbituric acid, any salt of bar-
bituric acid or any derivation of barbituric acid which has been
designated under the provisions of the Federal Drug Act as habit
forming; (ii) any drug containing any quantity of amphetamine
or any of its optical isomers, any salt of amphetamine or any salt of
an optical isomer or amphetamine; (iii) any substance designated
under the provisions of the Federal Drug Act as habit forming
because of its stimulant effect on the central nervous system; (iv)
any drug containing any quantity of any substance designated
under the provisions of the Federal Drug Act as having potential
for abuse due to its hallucinogenic effect or its depressant or stimu-
lant effect on the central nervous system. ; BUT SHALL NOT
MEAN ANY NARCOTIC DRUG AS DEFINED BY SECTION 276
OF ARTICLE 27 OF THIS CODE.

(6)    The term "manufacture, compound or process" includes re-
packaging or otherwise changing the container, wrapper, or labeling
of any drug package, in the furtherance of the distribution of the
drug from the original place of manufacture to the person making
final delivery or sale to the ultimate consumer. "Manufacturers,
compounders, and processors" refer to any persons engaged in
activities defined under this subsection.

(7)    The term "practitioner" means physician, dentist, veteri-
narian or other person licensed in this State to prescribe or admin-
ister drugs subject to this section.

(8)    The term "Federal Drug Act" means the Federal Food,
Drug and Cosmetic Act 52 Stat. 1040 (1938), 21 U.S.C. Sections
301-392, as amended from time to time.

(b) No one but the following persons shall manufacture, com-
pound or process any depressant or stimulant drug, except those
exempted under Section 511 (f) of the Federal Drug Act, in this

State:

(1) Manufacturers, compounders, and processors regularly en-
gaged in preparing pharmaceutical chemicals or prescription drugs
for distribution to pharmacies, hospitals, clinics, public health
agencies, physicians, laboratories, research or educational institu-